Haber Trilix Advisors »

Jazz Pharmaceuticals shares owned by Haber Trilix Advisors

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by Haber Trilix Advisors from 13F filings

Historical chart of Haber Trilix Advisors investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by Haber Trilix Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by Haber Trilix Advisors

Quarter filed Position value Share count Share price at filing
2013-06-30 $81k 1.2k 68.64

More positions owned by Haber Trilix Advisors

Rbc Cad (RY)
Suncor Energy (SU)
Toronto Dominion Bk Ont Com New (TD)
Bk Nova Cad (BNS)
Sun Life Financial (SLF)
Canadian Natural Resources (CNQ)
Canadian Natl Ry (CNI)
Potash Corp. Of Saskatchewan I
Bce Com New (BCE)
Magna Intl Inc cl a (MGA)
Bank Of Montreal Cadcom (BMO)
Cenovus Energy (CVE)
Rogers Communications CL B (RCI)
Goldcorp
Brookfield Asset Mgmt Cl A Ltd Vt Sh

View all positions for Haber Trilix Advisors

Top funds holding Jazz Pharmaceuticals

Vanguard Group
LSV Asset Management
Polaris Capital Management
Jpmorgan Chase & Co
Wellington Management Company
Pacer Advisors
EcoR1 Capital
Franklin Resources
Dimensional Fund Advisors
Bnp Paribas Investment Partners
Samlyn Capital
Millennium Management
Bank of New York Mellon
Charles Schwab Investment Management
Avidity Partners Management

View all funds holding Jazz Pharmaceuticals